Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
571516
Created by
admin on Sat Dec 16 11:31:38 UTC 2023 , Edited by admin on Sat Dec 16 11:31:38 UTC 2023
|
||
|
FDA ORPHAN DRUG |
603617
Created by
admin on Sat Dec 16 11:31:38 UTC 2023 , Edited by admin on Sat Dec 16 11:31:38 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Adegramotide
Created by
admin on Sat Dec 16 11:31:38 UTC 2023 , Edited by admin on Sat Dec 16 11:31:38 UTC 2023
|
PRIMARY | |||
|
C171727
Created by
admin on Sat Dec 16 11:31:38 UTC 2023 , Edited by admin on Sat Dec 16 11:31:38 UTC 2023
|
PRIMARY | |||
|
121488164
Created by
admin on Sat Dec 16 11:31:38 UTC 2023 , Edited by admin on Sat Dec 16 11:31:38 UTC 2023
|
PRIMARY | |||
|
EF-93
Created by
admin on Sat Dec 16 11:31:38 UTC 2023 , Edited by admin on Sat Dec 16 11:31:38 UTC 2023
|
PRIMARY | |||
|
10324
Created by
admin on Sat Dec 16 11:31:38 UTC 2023 , Edited by admin on Sat Dec 16 11:31:38 UTC 2023
|
PRIMARY | |||
|
DTXSID701337273
Created by
admin on Sat Dec 16 11:31:38 UTC 2023 , Edited by admin on Sat Dec 16 11:31:38 UTC 2023
|
PRIMARY | |||
|
1252802-98-4
Created by
admin on Sat Dec 16 11:31:38 UTC 2023 , Edited by admin on Sat Dec 16 11:31:38 UTC 2023
|
PRIMARY | |||
|
4XQ7W02EQ0
Created by
admin on Sat Dec 16 11:31:38 UTC 2023 , Edited by admin on Sat Dec 16 11:31:38 UTC 2023
|
PRIMARY |
ACTIVE MOIETY